Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Seneca Biopharma Inc. (SNCA)

0.5934   -0.026 (-4.2%) 09-20 20:51
Open: 0.614 Pre. Close: 0.6194
High: 0.6192 Low: 0.593
Volume: 242,403 Market Cap: 10M
Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. The company is headquartered in Germantown, Maryland and currently employs 6 full-time employees. The firm is focused on developing treatments for diseases of unmet medical need. The company is focused on finding and acquiring new assets, sciences and technologies that provide therapies for patients. The company intends to focus on developing a pipeline of biopharmaceuticals and commercializing those products.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.621 - 0.624 0.624 - 0.626
Low: 0.573 - 0.576 0.576 - 0.579
Close: 0.615 - 0.62 0.62 - 0.625

Technical analysis

as of: 2020-09-18 4:35:43 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 0.80     One year: 0.92
Support: Support1: 0.52    Support2: 0.43
Resistance: Resistance1: 0.69    Resistance2: 0.79
Pivot: 0.64
Moving Average: MA(5): 0.60     MA(20): 0.66
MA(100): 0.78     MA(250): 0.93
MACD: MACD(12,26): -0.05     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 33.04     %D(3): 31.45
RSI: RSI(14): 41.77
52-week: High: 4.09  Low: 0.50  Change(%): -63.4
Average Vol(K): 3-Month: 60721  10-Days: 50033

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
SNCA has closed above bottom band by 42.2%. Bollinger Bands are 22.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 16 Sep 2020
$SNCA Seneca Biopharma Files For Mixed Shelf Of Upto $100 Mln - CML News

Thu, 10 Sep 2020
Seneca Biopharma, Inc. Announces Completion of Phase II Clinical Study in China for the Treatment of Ischemic Stroke - PRNewswire

Wed, 02 Sep 2020
Letter from Seneca Biopharma's Executive Chairman - PRNewswire

Thu, 27 Aug 2020
Learn Why Seneca Biopharma, Inc. (SNCA) Has Been Active In the Market Recently - Invest Million

Thu, 30 Jul 2020
Seneca Biopharma Inc. (SNCA) distance from 200-day Simple Moving Average is $0.9220: Right on the Precipice - News Daemon

Wed, 08 Jul 2020
Seneca Biopharma Inc. (NASDAQ:SNCA) is Holding Steady - The Oracle Dispatch

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 17
Shares Float (M) 16
% Held by Insiders 4.21
% Held by Institutions 7.44
Shares Short (K) 90
Shares Short P. Month (K) 73

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin -59856.26
Return on Assets (ttm) -49.0
Return on Equity (ttm) -146.5
Qtrly Rev. Growth -68.3
Gross Profit (p.s.) 0.001
Sales Per Share 0.001
EBITDA (p.s.) -0.461
Qtrly Earnings Growth
Operating Cash Flow (M) -8
Levered Free Cash Flow (M) -5

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales 786.95
Price to Cash Flow -1.38

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.